πŸ‡ΊπŸ‡Έ FDA
Patent

US 10968248

Trinucleotide mRNA cap analogs

granted A61KA61K31/7125A61K45/06

Quick answer

US patent 10968248 (Trinucleotide mRNA cap analogs) held by Arcturus, Inc. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcturus, Inc.
Grant date
Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7125, A61K45/06